Android app Apple app link

Corcept Therapeutics Incorporated (CORT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$37.50

$0.97 (2.66%)
Last update: 03:25 PM EST
Day's range
$36.2
Day's range
$37.7

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/02/2026 H.C. Wainwright Swayampakula Ramakanth $90.00 $36.35   147.59%
01/02/2026 Canaccord Genuity Edward Nash $99.00 $36.90   168.32%
12/16/2025 UBS Ashwani Verma $95.00 $87.30   8.82%
05/06/2025 Truist Financial Joon Lee $135.00 $70.74   90.84%
05/06/2025 H.C. Wainwright Swayampakula Ramakanth $145.00 $73.94   96.1%
10/18/2024 H.C. Wainwright Swayampakula Ramakanth $80.00 $47.17   69.6%
09/30/2024 Truist Financial Joon Lee $76.00 $43.93   73%
08/15/2024 Canaccord Genuity Edward Nash $78.00 $34.71   124.72%
07/30/2024 Piper Sandler David Amsellem $38.00 $36.12   5.2%
07/30/2024 H.C. Wainwright Swayampakula Ramakanth $45.00 $36.53   23.19%
06/12/2024 Canaccord Genuity Edward Nash $38.00 $32.79   15.89%
06/10/2024 Piper Sandler David Amsellem $35.00 $31.51   11.08%
06/04/2024 Truist Financial Joon Lee $65.00 $31.59   105.76%
05/02/2024 H.C. Wainwright Swayampakula Ramakanth $40.00 $23.88   67.5%

Corcept Therapeutics Incorporated FAQ's

Corcept Therapeutics Incorporated has been rated by research analysts at H.C. Wainwright, Canaccord Genuity, Truist Financial, Wolfe Research, UBS, Piper Sandler in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.